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RHINOVIRUS-ASSOCIATED WHEEZING AND ASTHMA IN YOUNG CHILDREN
Zofia Piotrowska (Supported by Jeffrey S. Kahn)
Section of Pediatric Infectious Diseases
Yale University School of Medicine, New Haven, CT

Human rhinoviruses (HRV) are a common cause of the common cold, and are thought to
be associated with asthma exacerbations in both children and adults. Recently, HRV have been
identified as a major cause of hospitalization in children < 5 years old. The purpose of this study
was too determine whether HRV are a cause of either wheezing and/or hospitalization in children
< 2 years old.
We used a PCR assay to screen for HRV infection in children < 2 years old: 1) with
symptoms of upper or lower respiratory tract disease without wheezing; 2) with wheezing; 3) who
were asymptomatic. A group of children who had a respiratory specimen submitted to a
diagnostic laboratory for whatever reason and who tested negative for four common viruses in the
clinical lab were also screened. All specimens were collected between January 1 and December
31, 2004. Phylogenetic analyses were performed on a majority of HRV isolates.
Overall, 28 (17%) of 165 children with symptoms of respiratory traction infection without
wheezing; 21 (26.3%) of 80 children with symptoms of respiratory tract infection and wheezing; 3
(3%) of 93 asymptomatic children and 47 (23.3%) of 202 children with specimens submitted to
the diagnostic laboratory tested positive for HRV. The difference between the rate of infection in
the asymptomatic group and each of the three other groups was statistically significant (p<0.01).
Among children with samples submitted to the diagnostic laboratory in whom HRV was the only
identified pathogen, 55% were hospitalized. This rate was similar to that observed for respiratory
syncytial virus (52.7%) among children of a similar age group and time period (P=0.85). Diverse
groups of HRV were circulating during the one-year study period.
We conclude that HRV are important pathogens among young children < 2 years old and
are responsible for a significant proportion of wheezing this age group. Among a group of children
with a respiratory specimen submitted to the diagnostic laboratory in whom a rhinovirus was the
only identified pathogen, a majority were hospitalized.
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I. BACKGROUND

Clinical significance of respiratory viruses

Viruses are an important cause of human disease worldwide. In particular,
viral respiratory tract infections are a major cause of illness in both the adult and
pediatric populations. Respiratory infections of viral etiology are particularly
prevalent among children and are a major cause of emergency room visits,
hospitalizations and significant medical costs in this population. In 1991, one
study estimated that parainfluenza virus infections in children lead to 250,000
emergency room visits, 70,000 hospitalizations and $190 million in medical costs
annually1. Likewise, approximately 100,000 children are hospitalized annually
due to respiratory syncytial virus (RSV) infection, resulting in an annual cost of
$300 million2, 3.
Although they are common among all age groups, viral respiratory tract
infections are particularly prevalent among young children. In a report from the
New Vaccine Surveillance Network, the rate of hospital admissions for acute
respiratory illness in children less than 5 years old was reported to be 180 per
10,000 children, and a respiratory virus was identified in 61% of these
hospitalizations (approximately 110 per 10,000 children)4. To compare the rates
of viral infection among children and adults, Hammond et al looked at the
percentage of lower respiratory tract disease which could be attributed to a viral
pathogen among patients of different ages5. In infants, viruses are responsible
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for up to 90% of cases of pneumonia. In children age 2 to 5 years 58% of lower
respiratory tract infections are viral, whereas in children older than 5 years viral
pathogens account for 37% of lower respiratory tract disease. In the adult
population, this percentage is much lower-- only 12% of lower respiratory tract
infections are associated with a viral etiology5. Although adults frequently suffer
from mild viral infections of the upper respiratory tract, virus-associated
pneumonias are relatively uncommon in this population. It is postulated that the
relative immaturity of the infant immune system and a lack of adaptive immunity
may lead to increased susceptibility to viral infections among our youngest
patients5.
Although the majority of viral respiratory tract infections cause disease of
mild to moderate severity, viruses can also be a significant cause of morbidity,
and even mortality. Among children, one fifth of the five million deaths due to
respiratory tract disease reported annually are associated with a viral infection6.
The mortality of viral illness is even higher among children in the developing
world, where it is estimated that 4-5 million children die of acute respiratory
infections each year, with viruses accounting for over half of these deaths7, 8.

A wide variety of viruses infect the human respiratory tract

There are over 200 viruses known to infect the respiratory tract,
representing a variety of viral families. Many of these pathogens were discovered
during a boom in the study of virology that occurred during the 1950s and 1960s.
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Prior to that time, the influenza viruses were the only known, filterable respiratory
viruses. The first influenza A virus was discovered in swine in 1931, and the first
human isolates of influenza A were identified two years later.9 The B and C
strains of influenza were discovered in 1940 and 1947, respectively. In 1953
Rowe, Huebner and Hilleman identified the first adenovirus and established its
significance in acute febrile respiratory tract disease10, 11. These discoveries
paved the way for the identification of other important respiratory viruses during
this decade, including the parainfluenza viruses, which were first isolated from
children with croup in 1954 and 195812. In 1954, Morris et al identified a
chimpanzee coryza agent, which was subsequently linked to isolates identified in
infants with bronchopneumonia and laryngotracheobronchitis, leading to the
identification of RSV in 195713, 14. In the same year, the first human rhinovirus
was isolated from the nasal washings of naval recruits with mild cold-like
symptoms15.
Many of the viruses discovered during this time are now known to
represent the most common respiratory pathogens. For example, influenza virus
is the most commonly-isolated viral respiratory pathogen among adults. Among
children, RSV causes the majority of clinically-significant viral infections of the
respiratory tract. In particular, RSV represents 24-36% of community-acquired
pneumonia in children, which can also be associated with parainfluenza virus 1,
2 and 3, human metapneumovirus (hMPV), influenza virus and adenovirus5. The
human rhinoviruses are the most common agents associated with the common
cold, and are known to cause up to 80% of cases of mild upper respiratory tract
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infections. The HRV are also associated with otitis media, sinusitis and, in
particular, with asthma exacerbations in both children and adults.

Epidemiology of respiratory viruses

The respiratory tract is a major portal of entry for human pathogens,
making viral respiratory tract infections extremely common around the world. By
definition, respiratory viruses are transmitted by airborne droplets. An infected
human or animal host can shed viral particles by any mechanism which spreads
respiratory secretions, including coughing, sneezing, or talking. Sneezing, in
particular, disperses up to a million tiny aerosolized virus-filled droplets less than
10µm in diameter6. Due to their small size, these droplets can remain suspended
in the air for minutes and be transmitted by inhalation to others in the vicinity.
Coughing, spitting and speaking, on the other hand, produce larger droplets
(>100 µm) which fall to the ground more rapidly, affecting only those in close
proximity immediately after they are released. Viral particles can also be
transmitted directly by passing oral and nasal secretions via hands or other direct
contact to another person’s nose or mouth.
While viral respiratory tract infections are common throughout the year, a
seasonal distribution of the “common cold” has been described. In particular,
rhinovirus-associated infections have been noted to peak in spring and fall
months16. Interestingly, Johnston et al noted an increase in HRV infection during
the academic school year, with decreased rates of infection during times of
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school rescess17. The association between viral infections and school attendance
suggests that such small, enclosed environments facilitate the transmission of
respiratory viruses through aerosolized particles or hand-mouth contact. This is
also supported by outbreaks of respiratory tract infections which are so
commonly seen in other closed communities such as long-term care facilities18.
Respiratory viruses, in particular, are likely to be spread by close contact
because large numbers of viral particles, 103-109 particles per ml of respiratory
secretions, are shed during the peak of infection6. In general, this peak infectivity
coincides with the period during which the patient is most likely to be sneezing
and coughing frequently, readily spreading contaminated respiratory secretions.
Furthermore, respiratory viruses are highly infectious; even a single viral particle
may be enough to initiate a respiratory tract infection. In this way, respiratory
viruses can spread easily and rapidly across populations, leading to frequent
outbreaks of respiratory tract infections.

Mechanisms of viral pathogenesis in the respiratory tract

Once inhaled, viral particles settle at different locations within the
respiratory tract depending on particle size. Large droplets (those >10µm in
diameter) may be deposited in the nasal turbinates while smaller particles may
travel to the lower respiratory tract and be trapped in the trachea or bronchioles.
Infection is initiated when a virion attaches to a susceptible epithelial cell via
appropriate ligand-receptor interactions. The virus then enters the cell, replicates,
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and, several hours later, may be released from the apical surface of the cell into
the lumen of the respiratory tract. Human defense mechanisms against viral
infection include alveolar macrophages, which phagocytose and inactivate the
viral particles before infection occurs. A thick layer of mucus lining the respiratory
tract traps viral particles leading them to be swallowed or expelled by coughing.
The mucus layer also contains virus-inactivating substances such as glycoprotein
inhibitors which neutralize influenza, while lung surfactant contains mannosebinding lectins which also have anti-viral activity. Finally, virus-infected epithelial
cells may produce and secrete interferon, which binds to interferon receptors on
neighboring cells, thereby protecting them from viral infection6.
In cases of re-infection, when pre-formed virus-specific antibodies are
already present in the respiratory tract, these antibodies bind to viral antigens,
blocking the pathogen’s ability to bind to and infect epithelial cells. In cases of
primary infection, viral infection may continue, relatively unhindered, for several
days before a humoral response is mounted. During this lag time, non-specific
immune mechanisms such as natural killer (NK) cells are activated by interferon
and act to lyse cells infected with virus. Shortly thereafter, T-lymphocytes are
recruited and trigger lymphokines to stimulate further immune response,
eventually leading to the production of virus-specific antibodies by Blymphocytes.
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Methods of Viral Detection:

Most common respiratory pathogens identified during the 1950s and
1960s were first characterized and studied by propagating the viral particles in
live cell lines. Such traditional cell culture methods remain an important tool used
by virology researchers, but they are now complemented by a variety of
molecular and antibody-based methods used to identify, diagnose and study viral
pathogens. Each of these methods has significant advantages and
disadvantages, outlined below. Together, these techniques provide scientists
with a variety of tools with which to study the epidemiology and molecular
characteristics of previously-known and newly-discovered viruses.

Cell culture
Traditionally, propagation of viral particles in cell culture served as the
main tool of researchers studying respiratory viruses. The main advantage of
traditional cell culture methods is the ability to identify a wide variety of viruses
and detect multiple viruses within a single sample. Furthermore, cell culture
requires no a priori knowledge of the virus which is being propagated, making it a
useful diagnostic tool in the clinical setting. By using cell lines of different origins
and different growth conditions, researchers can propagate a multitude of
viruses. Viruses which have been shown to propagate in cell culture are
numerous and include common pathogens such as adenovirus, cytomegalovirus
(CMV), polioviruses, coxsackieviruses, echoviruses, herpes simplex virus (HSV),
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influenza A and B viruses, measles virus, mumps virus, parainfluenza virus types
1 to 4, RSV, rhinoviruses, and varicella-zoster virus (VZV), as well as Ebola
virus, severe acute respiratory syndrome coronavirus (SARS-CoV) and hMPV19.
The proliferation of viruses is detected by identifying cytopathic effects
(CPE) of the viral particles on cells in the culture. CPE can include a variety of
morphologic changes, including swelling, shrinking, rounding or clustering of
cells, syncytium formation or even destruction of the monolayer. The degree of
CPE varies with the viral species being studied; some viruses, such as HSV,
produce easily-visible CPE within 24 hours of culture inoculation19. Most viruses,
however, take days to weeks to develop CPE, and the effects they produce can
be subtle. Thus, the detection of viral propagation in cell culture by identification
of CPE can be a slow, time-consuming and operator-dependent process.
Moreover, cell culture can have poor sensitivity in detecting viruses present in
low titers.
While these techniques have lead to many important discoveries in the
field of virology and cell culture remains an important scientific tool, the
introduction of antibody-based and molecular probe-based methods of viral
detection are important new tools which have revolutionized the study of viral
pathogens.

Viral antigen detection and serologic assays
In techniques such as immunofluorescence (IF), fluorescence-labeled
antibodies specific to particular viral antigens are used to detect even small
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amounts of viral particles in cell culture and directly within tissues. Fluorescencelabeled antibodies were first used as a diagnostic tool in clinical virology in 1956,
when Liu used these antibodies to detect influenza virus antigen in nasal
smears20. In the 1970s, the introduction of monoclonal antibodies allowed
scientists to create antibodies specific to individual viruses. This development
revolutionized our ability to detect and study pathogens which had been difficult
to detect through traditional cell culture methods. In the 1980s, monoclonal
antibodies were introduced as a diagnostic method and improved our ability to
detect a variety of viral antigens in the clinical setting.
Clinically, serologic assays to detect human antibodies to a desired virus
are an alternative to the direct detection of viral antigens. While serologic assays
are an important tool in the clinical laboratory, these methods are not without
their own limitations. First, not all clinically significant viral infections will generate
a detectable serologic response in the human host. For example, as many as
30% of culture-positive cases of influenza infection are serologically negative1.
Moreover, many antibodies may cross-react with viral antigens from multiple
related viruses; for example, antibodies to the parainfluenza viruses display
significant cross-reactivity between the different types of parainfluenza, making it
difficult to distinguish between them21. Finally, serologic assays may not be
useful in the acute setting, as it may take up to 2-4 weeks for increased serologic
titers to a particular virus to be detectable.
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Molecular Methods
Although cell culture techniques are still considered, by many, to be the
“gold standard” of viral diagnostics, the introduction of polymerase chain reaction
(PCR) in 1985, and the subsequent development of other molecular probe-based
methods of viral detection, have revolutionized the study of viruses. In particular,
a variety of techniques commonly known as nucleic acid amplification tests
(NAATs) allow researchers to rapidly and efficiently detect viral particles with a
high degree of sensitivity. These methods also avoid the need for highlyexperienced observers to detect subtle effects of CPE. Perhaps most
importantly, unlike cell culture, the detection of virus by NAAT does not require
viable viral particles. Finally, NAAT techniques can detect viral particles even
before viral antigens are present in sufficient quantities to be detected by
immunofluorescence techniques. A variety of techniques can be classified in the
NAAT category, including polymerase chain reaction (PCR), reversetranscriptase polymerase chain reaction (RT-PCR,) the nucleic acid sequencebased amplification (NASBA), real-time PCR techniques where amplification and
detection occur simultaneously, and many others.
Most authors agree that molecular diagnostic assays are rapidly becoming
the new gold standard in virus detection. Their sensitivity is unparalleled,
reported to be 12-30% higher than cell culture techniques when appropriate
controls are included to ensure the validity of the assay22. PCR-based techniques
utilize short oligonucleotide primers that specifically target known segments of
DNA within a desired viral genome. These sequence serve as the basis for
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amplification of the desired fragment. PCR-based assays are extremely
sensitive, capable of detecting even 1 to 10 copies of target DNA23. Moreover,
PCR amplification is rapid, easy and relatively inexpensive, making it an ideal
target for the development of new diagnostic tests. By including a reverse
transcriptase-mediated amplification step, PCR can also be used to detect RNA
viruses via RT-PCR.
Multiplex PCR includes primers targeting nucleic acid sequences of
multiple viruses and allows for the detection of several viruses within a single
PCR reaction. Recently, researchers have been working to develop
commercially-available multiplex PCR kits for use in the clinical virology
laboratory. For example, the Hexaplex PCR kit is capable of detecting seven of
the most common respiratory viruses—RSV A and B, influenza A and B, hPIV1,
2 and 3—with 100% sensitivity and 98% specificity.24
Finally, PCR and RT-PCR-based assays allow researchers to determine
the nucleic acid sequence of amplified nucleic acid fragments. This sequence
data can then be used to perform phylogenetic analyses of viral isolates and to
determine their molecular epidemiology. In this study, RT-PCR screening for the
human rhinoviruses and sequencing of amplified fragments will be used to
determine the molecular epidemiology of the HRV circulating in New Haven,
Connecticut during 2004.
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The Human Rhinoviruses

As previously mentioned, the human rhinoviruses have long been known
to be the primary pathogen responsible for mild upper respiratory tract infections
known as the “common cold.” Recent studies suggest that rhinoviruses are
responsible for up to 80% of cold cases 25. The majority of common cold cases
are brief and mild in nature; the median duration of illness is seven days, with
symptoms usually peaking 1-3 days after onset of infection, persisting for 2-3
days and then gradually improving26. Symptoms generally associated with HRV
infection are mild and may include sneezing, nasal obstruction and/or discharge,
sore throat, headache, cough and malaise. The physical exam is usually normal,
with the exception of nasal congestion. Laboratory studies may show mild
neutrophilia and leukopenia on the first day of illness27, but these values typically
normalize within 1-2 days and thus are unlikely to be detected during routine
medical visits. In addition to the common cold, HRV are also associated with
otitis media and sinusitis in children, as well as with more serious infections of
the upper and lower respiratory tract 28, 29.
The first HRV was isolated in 1957 by exposing rhesus monkey kidney
tissue cultures to nasal washings from persons with colds15. The genus name
was suggested in 1960, and was based upon the location of primary infection in
the upper respiratory tract. A variety of culture conditions and cell lines quickly
permitted researchers to appreciate the vast variety of rhinovirus serotypes in
circulation and within seven years of the initial characterization of rhinoviruses
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over 30 serotypes had been identified30. To date, over 100 genotypically and
serotypically diverse HRV are known to be circulating throughout the world.
Moreover, new HRV continue to be discovered 31, suggesting that this genus may
be even more diverse than previously thought.
Despite the large diversity of known HRV serotypes, recent work has
demonstrated that many of these viruses share common means of entry into the
host cell. As a result, some researchers divide the rhinoviruses into major and
minor groups based on cellular receptor usage32. The major group, comprising
about 90% of known HRV serotypes, is known to enter cells via the intercellular
adhesion molecule-1 (ICAM-1) receptor33. However, a small minority, about 10%
of HRV serotypes, use the low-density lipoprotein (LDL) receptor to enter cells
and deposit genomic material34.
The HRV are members of the Picornaviridae virus family. As the name
suggests, members of this family are non-enveloped viruses containing a small
(pico = small) RNA genome. The single-stranded, positive-sense genome is
surrounded by a protein shell to create a simple, spherical virion with a diameter
of about 30nm. In addition to the HRV, this large family contains multiple other
important human pathogens including hepatitis A virus, poliovirus, as well as
many human cosxackieviruses, echoviruses and enteroviruses. Among these,
rhinoviruses are related most closely to the enteroviruses. However, HRV can be
easily distinguished from other related viruses by their instability in acidic
conditions (pH values of less than 6.0.) This is in contrast to the enteroviruses,
hepatoviruses and cardioviruses, whose members are acid stable and retain
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infectivity at pH values of 3.0 and below35. This characteristic influences the sites
of replication of these pathogens. For example, the acid-stable enteroviruses are
able to pass through the acidic environment of the stomach and retain their
infectious nature in the intestinal tract. The rhinoviruses, however, cannot
replicate in the alimentary tract and their primary site of infection is the
respiratory tract. Moreover, in contrast to enteroviruses, many serotypes of
rhinovirus are thermostable at temperatures up to 50°C, and can survive for days
exposed to the environment at ambient temperatures of 24 to 36°C26.
The single-stranded, positive-sense RNA genome of the Picornaviridae is
translated immediately upon entry into the cell to produce all the proteins
required for viral replication. The size of the genome varies in length among the
Picornaviridae, ranging from 7,209 to 8,450 bases. The length of the HRV
genome is among the shortest of the family, about 7,200 nucleotides. Like other
members of the family, the HRV genome contains a single open reading frame
(ORF) that is translated into one long polyprotein and subsequently processed
into mature proteins by virus specific proteases. The HRV genome (see figure
1A) contains four structural proteins, VP1-4. The structure of the human
rhinovirus is very simple, with an icosahedral capsid composed of 60 identical
subunits arranged into 12 pentamers (see figure 1C). The four structural proteins
VP1-4, make up each subunit (see figure 1D), with the VP1, 2 and 3 proteins on
the capsid surface and the VP4 protein closely associated with the viral RNA
genome on the inner surface of the capsid. Accordingly, VP1-3 are antigenic and
are known to be the part of the genome with the highest variability36.
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In addition, all picornaviridae contain a 5’-untranslated region (5’-UTR)
which contains sequences that control genome replication and translation,
including a complex structure known as the internal ribosome entry site (IRES),
which can bind ribosomal subunits directly. The 5’-UTR of the HRV is about 620
basepairs in length and is highly conserved among the different HRV serotypes,
with about 90% sequence homology between any two HRVs37. Regions of the 5’UTR have been used to design molecular probes capable of detecting multiple
rhinovirus serotypes within a single assay. Oligonucleotide PCR primers
targeting the 5’UTR of HRV were used in this study.

The role of rhinoviruses in asthma exacerbation

In addition to their role as a major cause of the common cold, HRV have
also been implicated in exacerbations of asthma among both adults 38 and
children 39. In their study of children seen in the emergency department with
wheezing, Duff et al demonstrated that in young children (those younger than 2
years) the major risk factors for acute wheezing episodes were RSV infection
and cigarette smoke exposure40. However, for children older than two years, viral
infections, and in particular HRV infection, were the greatest risk factors for
wheezing. A history of respiratory allergies was also identified as a risk factor for
wheezing in older children, suggesting that respiratory allergies and HRV
infection may have a synergistic effect in increasing the likelihood of wheezing
episodes40, 41. Furthermore, Johnston et al demonstrated that 80-85% of school-
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aged children with a history of asthma were infected with a virus during wheezing
episodes, and that the most commonly-isolated virus in this population was
HRV39. Finally, in adults, about one half of asthma exacerbations can be
attributed to rhinovirus infection42. However, given the fact that HRV are among
the most common respiratory viruses, the association between HRV and asthma
exacerbation merits further investigation. Does the presence of HRV necessarily
cause disease? While these data suggest that viral infections, particularly HRV
infections, are associated with the development of asthma exacerbation or
wheezing in children and adults with pre-existing asthma, few studies have
compared the rates of infection among wheezing patients to those of
asymptomatic controls.
The molecular mechanisms underlying rhinovirus-induced asthma
exacerbations remain an area of active research. Most researchers agree that
the pathologic effects of HRV infection occur mainly at the level of the bronchial
epithelium. Patients with asthma, in particular, are thought to have an especially
fragile bronchial epithelium which is susceptible to the cytotoxic effects of HRV
infection. Some studies suggest that the major HRV cell surface receptor
molecule, ICAM-1, may also play a role in allergic inflammation of the airways43,
and that HRV may, in fact, act to upregulate ICAM-1 receptors via release of the
chemokine NF-kappa B44. NF-kappa B also up-regulates other proinflammatory
cytokines and chemokines. Specifically, HRV infection of airway epithelial cells is
known to increase levels of interleukins involved in B- and T-cell maturation and
recruitment of neutrophils. Moreover, HRV infection increases levels of IL-16, an
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interleukin known to be involved in chemotaxis of eosinophils and monocytes.45
Finally, airway epithelial cells infected by an HRV are also known to product the
chemokines eotaxin and RANTES (Regulated upon Activation,
Normal T-cell Expressed and Secreted), which are both known to be involved in
the chemotaxis of eosinophils leading to airway inflammation45.
In addition to inducing a chemokine profile favoring an allergic,
proinflammatory response, infection with an HRV is also believed to promote a
type 2 inflammatory response, characterized by high IL-4 levels. Researchers
have noted that asthmatic individuals may have a deficient type 1 inflammatory
response, with low levels of characteristic cytokines such as interferon-gamma
and low interferon-gamma:IL-4 ratios, which may lead to low antiviral activity and
a predisposition to HRV infection in these patients46. Therefore, asthmatic
patients may clear HRV infections more slowly, allowing for the development of
airway inflammation and, potentially, asthma exacerbation.

The current study

Recently, Miller et al reported an association between HRV infection and
hospitalization in children < 5 years old 47. While these studies suggest that HRV
infections are common and are likely the cause of a substantial proportion of
respiratory tract infections, the prevalence of this pathogen among asymptomatic
children, for the most part, has not been studied suggesting that the presence of
HRV does not necessarily cause disease. Therefore the role of these viruses in
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respiratory tract disease remains poorly defined.
In order to further investigate the association between HRV and lower
respiratory tract disease, including wheezing, among young children, we
screened specimens obtained from children < 2 years old between January and
December 2004 for HRV and compared these results to results from a group of
asymptomatic controls whose specimens were obtained during the same year.
We also screened specimens submitted to a clinical diagnostic laboratory for
HRV. Lastly, we defined the molecular epidemiology of HRV during a 1 year
period in New Haven, Connecticut.
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II. STATEMENT OF PURPOSE

Hypothesis:

Rhinovirus infection is a major cause of wheezing and respiratory illness in young
children, and rates of rhinovirus infection are significantly higher among sick
children than among asymptomatic controls.

Specific Aims:

1.

To define the epidemiology of HRV infection among children < 2 years
old in New Haven, CT

2.

To determine whether HRV are a cause of wheezing and other
respiratory tract disease in this population

3.

To determine the molecular epidemiology of HRV strains circulating in
New Haven, CT in 2004

4.

To determine the clinical characteristics of HRV infection among
children with HRV-positive respiratory specimens submitted to a
diagnostic laboratory
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III. METHODS

Specimens

Nasopharyngeal aspirates were collected from children < 2 years old
between January and December 2004. Respiratory specimens from all groups
were stored at –20OC after addition of an equal volume of “viral freezing media”
(2X Dulbecco’s modified Eagle medium, 200 mmol/L MgSO4 and 100 mmol/L
HEPES [pH 7.5]). Study subjects originated from four clinical groups, as
summarized in table 1. Groups 1-3 were patients identified prospectively in the
Yale Primary Care Center (PCC). Group 1 included children who had evidence of
upper and/or lower respiratory tract infection without wheezing (PCC nonwheezing); Group 2 included children who had evidence of wheezing (PCC
wheezing); Group 3 included asymptomatic children who were seen for routine
well-child visits and did not have any evidence of either upper or lower
respiratory tract infection (Asymptomatic). Group 4 included children from whom
a respiratory specimen was submitted to the Yale-New Haven Hospital Clinical
Virology Laboratory (Clinical Virology) for testing for respiratory viruses.
Specimens from patients in Group 4 were submitted at the discretion of the
medical team from the Emergency Department, inpatient wards, intensive care
units and hospital-affiliated outpatient urgent care clinics. Patients were included
in Group 4 only if the results of the tests on the specimens were negative for
adenovirus, parainfluenza virus 1-3, influenza A and B and RSV by direct
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immunofluorescence assay (DFA). Furthermore, all specimens from each group
were screen for the human bocavirus (HBoV) by PCR as previously described 48.

RNA extraction, RT-PCR

RNA was extracted using a commercially-available nucleic acid
purification kit (Qiagen, Valencia, CA) according to manufacturer’s instructions.
Reverse transcriptase (RT) was performed using random hexamer primers and
MuMLV RT (New England Biolabs, Beverly, MA), according to the
manufacturer’s specifications. PCR amplification was performed using the PICOF3 and PICO-R3 primers 49 which amplify a 115-bp region of the picornavirus 5’untranslated region (5’-UTR). For sequencing purposes, a larger (394 bp) portion
of the picornavirus 5’-UTR was amplified using the OL-26 and OL-27 primers 50
PCR amplification was performed using HotStar Taq polymerase (Qiagen)
according to the manufacturer’s instructions. PCR amplification cycles were
performed as follows: 95 OC for 15 min, followed by 40 cycles of 94 OC for 1 min,
58 OC for 1 min, and 72 OC for 1 min, and completed by a final extension cycle at
72 OC for 10 minutes. Each set of PCR included appropriate positive and
negative controls. All primers used in this study were synthesized by the
Oligonucleotide Laboratory, Department of Pathology, Yale University School of
Medicine.
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Sequencing and Phylogenetic Analysis:

All amplicons were sequenced using an Applied Biosystems 3730 XL DNA
Analyzer at the W. M. Keck Biotechnology Resource Laboratory, Yale University
School of Medicine. Alignments and phylogenetic analysis were performed using
Lasergene MegAlign Software (version 5.05; DNAstar) with use of the clustal W
alignment method.

Clinical data

The clinical data for patients in Groups 1-3 was collected on enrollment.
The medical records of all HRV-positive children from Group 4 (Clinical Virology)
were reviewed. Demographic and clinical characteristics were recorded on a
standardized collection form. Specimen collection and collection of clinical data
were approved by the Yale University Human Investigation Committee and
collection of data was compliant with HIPAA regulations.

Statistical analysis

Fisher’s exact tests were used to determine whether the differences in
percentage of HRV-positive specimens among different groups were statistically
significant.
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IV. RESULTS

Overall, 447 symptomatic children (Groups 1, 2 and 4) and 93
asymptomatic controls (Group 3) were screened for HRV (Table 2, Figure 2). Of
the symptomatic children screened, 245 (55%) were seen in the PCC with
symptoms of respiratory tract disease and 202 (45%) had specimens submitted
to the Clinical Virology Laboratory. A total of 102 isolates tested positive for a
picornavirus by initial PCR screening with the PICO-F3 and PICO-R3 primers.
Three of these isolates were non-HRV and were not included in the analyses
(see below).
In all, 28 of 165 children with respiratory symptoms without wheezing
(17.0%) (Group 1), 21 of 80 children with wheezing (26.3%) (Group 2), 47 of 202
samples obtained from the Clinical Virology Laboratory (23.3%) (Group 4) and 3
of 93 asymptomatic children (3.2%) (Group 3) had HRV identified in the sample.
The differences between each of the three groups of symptomatic children (1, 2,
4) and the asymptomatic controls (Group 3) were statistically significant (p<0.01).
The difference in the proportion with HRV between the wheezing (Group 2) and
non-wheezing (Group 1) children seen at the Primary Care Center (26.3% vs.
17.0) was not statistically significant (p<0.09).
The monthly distribution of HRV-positive specimens is shown in figure 3.
HRV-positive specimens were detected throughout the year with the exception of
July. HRV-positive specimens were most frequently identified in the months of
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October-December and April-May. The three cases of asymptomatic HRVinfection occurred in March and April.
The distribution of HRV-positive specimens by age is shown in figure 4. All
children enrolled in the study were < 2 years old. The youngest child from whom
HRV was identified was 15 days old.
The clinical features of 40 of the 47 HRV-positive children the children in
the Clinical Virology group (Group 4) are shown in Table 3. Of the 7 children who
were not included in the analyses, 2 were co-infected with HBoV and the medical
records of the remaining 5 patients were not available for review. Overall, 22
(55%) of 40 of HRV-positive patients in this group were male. The most common
features observed at or around the time of specimen collection included fever
(31/40 patients, 77.5%), cough (24/40 patients, 60.0%) and rhinorrhea (24/40
patients, 60.0%). Wheezing was noted in 19 of 40 (47.2%) patients, and chest
retractions were observed in 18 of 40 (45%) patients. Only 6 (15.4%) of 39
patients had a prior documented history of wheezing or of asthma. Of the 25
patients for whom chest radiographs were obtained, 5 (20%) patients had
abnormal findings. Abnormalities included hyperinflation, peribronchial cuffing
and atelectasis. Hypoxia was not a common feature of HRV infection, noted in
only 6 (15.0%) of 40 patients in this population. Nine of the 40 HRV-positive
patients had comorbid conditions, which included prematurity, pulmonary
abnormalities, congenital heart abnormalities and metabolic disorder.
Of the 40 HRV-positive children in the Clinical Virology Group, 22 (55%)
were hospitalized. We compared this rate of hospitalization to that of children
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infected with another common respiratory virus, RSV. We reviewed the medical
records of every 4th child < 2 years old who had a respiratory specimen submitted
to the same diagnostic laboratory during the same study period and who tested
positive for RSV. Of the 93 children in the RSV-infected group, 49 (52.7%) were
hospitalized. The percentage of HRV-positive children who were hospitalized
(55%) and the percentage of RSV-infected children who were hospitalized
(52.7%) were not statistically significantly different (p=0.85).
A subset (87 isolates) of the 102 picornavirus-positive specimens was
sequenced to confirm HRV infection. Among these 87 isolates, 84 (96.6%) had
sequences that matched known HRV sequences and 3 (3.4%) most closely
resembled non-HRV picornaviruses: the sequence of 2 of these isolates were
consistent with a human Coxsackie virus and the sequence of one isolate
resembled a human enterovirus. As stated above, these 3 specimens were
excluded. Of the 15 picornavirus-positive specimens which were not sequenced,
it is likely that 3.4%, or about (less than) one isolate, was a non-HRV
picornavirus. Therefore, these 15 specimens were considered to represent HRV
infection and were included in further analyses. While it is possible, albeit
unlikely, that one or more of these 15 isolates were non-HRV, we performed the
statistical analyses with these 15 isolates omitted from the data set (data not
shown). The results of statistical comparisons were unchanged.
Phylogenetic analysis of HRV-positive specimens indicated that a wide
variety of HRV genotypes circulated in New Haven throughout 2004 (figure 5).
The data suggests that as many as eleven different genotypes of HRV may have
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been circulating in Connecticut during the study period. Some identified
sequences showed close identity to previously described HRV serotypes and
genotypes, though some of the identified sequences showed as little as 82%
identity with previously described HRV strains. No association could be identified
between particular genotypes and either specific clinical groups or clinical
features within children from Group 4. Specifically, genotypes were not clustered
among patients from the wheezing group or among patients with clinical features
of wheezing in the clinical virology group. Likewise, there appears to be no
association between particular genotypes and the month or season of specimen
collection (data not shown).
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V. DISCUSSION

We found a high rate of HRV infection (17-26%) among sick children in
New Haven, CT compared with asymptomatic control patients (3%). The data
support recent findings that HRV are a major cause of morbidity among young
children and suggest that the detection of these viruses does not simply
represent asymptomatic infection.
We detected HRV in the respiratory specimens of 22.3% of children who
had samples submitted to the Clinical Virology laboratory and who were negative
for RSV, parainfluenza virus 1-3, influenza A and B, adenovirus and HBoV. This
rate of infection is higher than the 8% rate of human metapneumovirus (hMPV)
infection previously detected in a similar population in New Haven 51. Other
researchers have found HRV to have a prevalence of 26% in sick children,
higher than the prevalence RSV, influenza, parainfluenza and enteroviruses 47.
This study and ours strongly suggest that HRV may be a more common
pathogen than other viruses traditionally associated with lower respiratory tract
infection.
Furthermore, 55% of children with specimens submitted to the Clinical
Virology laboratory who were infected only with an HRV were hospitalized at the
time of specimen collection. This suggests that HRV infection may be a major
cause of hospitalization among young children. Indeed, the percentage of HRVinfected children who were hospitalized was not significantly different from the
percentage of comparable RSV-infected children who were hospitalized. The
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high prevalence of HRV, along with considerable morbidity as evidenced by high
rates of hospitalizations, suggests that these viruses are of major clinical
significance and that a rapid sensitive assay capable of detecting most rhinovirus
strains may be an important diagnostic tool.
Our study suggests that only a small percentage (3.3%) of isolates
detected using picornavirus-specific primers represent non-rhinovirus
picornavirus infection. In this study, we detected two cases of infection with
Coxsackie virus and one case of enterovirus infection. Likewise, Miller et al
identified enterovirus infection in 2% of their study population 47. These data
confirm that, within the picornavirus family, HRV are overwhelmingly the most
common pathogen of the respiratory tract in young children with respiratory
symptoms.
Few other studies have included sequence data and phylogenetic
analyses of HRV strains. Our phylogenetic analysis confirms the broad genetic
diversity of HRV circulating in Connecticut over a one-year period. These viruses
show a large number of nucleotide polymorphisms, suggesting that our current
understanding of the diversity within this genus may underestimate the true
genetic diversity of HRV strains in circulation.
Based on our data, no particular HRV strains are more likely to cause
wheezing and asthma exacerbation than others. Likewise, it does not appear that
certain isolates are more likely to cause severe disease and hospitalization than
others at least among those found in 2004. The previously-described seasonality
of HRV infection, with peaks in spring and fall months16, is not supported by our
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phylogenetic analysis. There appears to be no association between particular
isolates and the seasonal distribution of this virus. While most cases of HRV
infection occurred during spring and fall-winter months, there does not appear to
have been any specific HRV isolates with peak activity during this period,
suggesting that these viruses do not have a true seasonal distribution.
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VI. CONCLUSIONS

We conclude that HRV are important pathogens among young children.
The clinical significance of HRV infection may have previously been
underestimated, as HRV appear to be more prevalent than other common
respiratory viruses, such as hMPV, in children seeking medical care. Rapid
diagnostic assays with a high degree of sensitivity for detecting this genotypically
diverse group of viruses may prove to have an important role in the diagnosis of
respiratory tract infection and of the cause of asthma exacerbations among
young children.
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VII. FIGURES

Figure 1, General structure of the rhiovirus genome and capsid.
A, Schematic representation of the rhinovirus genome. B, 3-dimensional
computer-enhanced electron micrography of HRV14. C, Icosahedral symmetry of
rhinovirus capsid. D, Arrangement of rhinovirus structural proteins VP1-3 on
capsid surface.
Adapted from Papadopoulos, NG and Johnston, SL. 2000. Rhinoviruses. In
Principles and Practice of Clinical Virology. AJ Zuckerman, JE Banatavala and
JR Pattison, editors. John Wiley & Sons. 329-343.

36

Figure 2, Results of RT-PCR screening for HRV by group.
Percent of HRV(+) specimens in each group is indicated. P-values versus
asymptomatic control are indicated for each group. Chi-square test was used for
each pair-wise comparison.
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Figure 3, Monthly distribution of HRV(+) specimens.
The total number of HRV(+) specimens per month is indicated. The breakdown
by group is indicated for each month.
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Figure 4, Distribution of HRV(+) individuals by age at time of specimen
collection.
All patients screened were < 2 years old. The total number of positive specimens
is indicated for each age group. The breakdown of each bar by study group is
indicated.
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Figure 5, Phylogenetic analysis of HRV isolates.
A 394 bp fragment of the 5’ untranslated region of the HRV genome was
amplified for sequence analysis. The phylogenetic tree was constructed using
sequence data from New Haven isolates in conjunction with reference
sequences obtained from GenBank (reference strains denoted by an asterisk, *)
Reference strains are identified by GenBank accession number and strain name.
New Haven isolates are identified by Kahn lab ID number.
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VIII. TABLES

Table 1: Study Groups
Group

Name

Description

1

Non-Wheezing (PCC)

Children < 2 years old evaluated in the PCC
with evidence of upper/lower respiratory tract
infection without wheezing.

2

Wheezing (PCC)

Children < 2 years old evaluated in the PCC
with evidence of upper/lower respiratory tract
infection including wheezing.

3

Asymptomatic

Children < 2 years old visiting the Yale
Primary Care Center (PCC) for routine wellchild visits with no evidence of respiratory
tract disease

4

Clinical Virology

Children < 2 years old who had specimens
submitted to the Clinical Virology Laboratory
that tested negative for RSV, influenza A and
B, human parainfluenza viruses 1-3 and
adenoviruses
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Table 2: Screening of children < 2 years of age for HRV, by Group

Group

Name

HRV-positive specimens/
Total no. of specimens screened (%)

1

Non-Wheezing (PCC)

28/165 (17.0)

2

Wheezing (PCC)

21/80 (26.3)

3

Asymptomatic

3/93 (3.2)

4

Clinical Virology

47/202 (23.3)

Table 3: Clinical features of HRV infection in the Clinical Virology group

Clinical Feature

Patients, no. (%)(a)

Fever(b)

31 (77.5)

Cough

24 (60.0)

Rhinorrhea

24 (60.0)

Wheezing

19 (47.5)

Retractions

18 (45.0)

Prior hx wheeze/asthma

6 (15.0)

Hypoxia(c)

6 (15.0)

Abnormal CXR (n=25)(d)

5 (20.0)

Comorbidity(e)

9 (22.5)

Hospitalized

22 (55.0)

Male

22 (55.0)

a. Percent of total (40 patients) b. Temperature > 38.0°C (Range 38.0°C-40.3°C,
mean 38.7°C). c. O2 sat <90%. d. Chest X-Ray abnormalities included
hyperinflation, infiltrates, peribronchial cuffing and atelectasis. e. Comorbidities
included prematurity, pulmonary abnormalities (hypoplastic left lung, primary
pulmonary hypertension, bronchopulmonary dysplasia) tracheostomy, congenital
heart abnormalities (double aortic arch, aortic stenosis, patent foramen ovale,
patent ductus arteriosis), DiGeorge syndrome, Very Long Chain Acyl CoA
Dehydrogenase Deficiency, and anoxic brain injury/seizure disorder.
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